VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
FTREFortrea Holdings Inc.
$15.31$1.4B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

FTRE logoFortrea Holdings Inc.(FTRE)Earnings, Financials & Key Ratios

FTRE•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryBiopharma Services and CROs
AboutFortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.Show more
  • Revenue$2.72B+1.0%
  • EBITDA$47M+163.2%
  • Net Income-$986M-200.2%
  • EPS (Diluted)-10.81-194.6%
  • Gross Margin15.63%-21.1%
  • EBITDA Margin1.74%+162.6%
  • Operating Margin-1.12%+81.3%
  • Net Margin-36.21%-197.2%
  • ROE-102.41%-379.6%

FTRE Key Insights

Fortrea Holdings Inc. (FTRE) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 88 (top 12%)
  • ✓Efficient asset utilization: 1.0x turnover

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when FTRE posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

FTRE Price & Volume

Fortrea Holdings Inc. (FTRE) stock price & volume — 10-year historical chart

Loading chart...

FTRE Growth Metrics

Fortrea Holdings Inc. (FTRE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-1.35%
TTM0.86%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM43.46%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM44.21%

Return on Capital

10 Years0.55%
5 Years0.55%
3 Years-1.91%
Last Year-1.38%

FTRE Recent Earnings

Fortrea Holdings Inc. (FTRE) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.16+433.3%
$0.03
Rev
$637M+1.3%
$629M
Q1 2026
Feb 26, 2026
Metric
Actual
Est
EPS
$0.09-43.8%
$0.16
Rev
$661M-0.7%
$665M
Q4 2025
Nov 5, 2025
Metric
Actual
Est
EPS
$0.12-25.0%
$0.16
Rev
$701M+5.4%
$665M
Q3 2025
Aug 6, 2025
Metric
Actual
Est
EPS
$0.19+216.7%
$0.06
Rev
$710M+13.9%
$623M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.16vs $0.03+433.3%
$637Mvs $629M+1.3%
Q1 2026Feb 26, 2026
$0.09vs $0.16-43.8%
$661Mvs $665M-0.7%
Q4 2025Nov 5, 2025
$0.12vs $0.16-25.0%
$701Mvs $665M+5.4%
Q3 2025Aug 6, 2025
$0.19vs $0.06+216.7%
$710Mvs $623M+13.9%
Based on last 12 quarters of dataView full earnings history →

FTRE Peer Comparison

Fortrea Holdings Inc. (FTRE) competitors in Biopharma Services and CROs — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
IQV logoIQVIQVIA Holdings Inc.Direct Competitor28.47B167.7721.405.87%8.33%22.11%2.44
CRL logoCRLCharles River Laboratories International, Inc.Direct Competitor8.91B185.00-63.57-0.85%-4.59%-5.66%0.95
MEDP logoMEDPMedpace Holdings, Inc.Direct Competitor13.14B460.2030.1219.97%17.19%120.89%0.55
PRA logoPRAProAssurance CorporationDirect Competitor1.27B24.6524.90-2.67%6.04%4.95%0.32
ICLR logoICLRICON Public Limited CompanyDirect Competitor11.18B146.0050.34-0.37%5.98%5.2%0.39
LH logoLHLabcorp Holdings Inc.Product Competitor21.05B255.8224.467.25%6.66%10.89%0.83
DGX logoDGXQuest Diagnostics IncorporatedProduct Competitor21.58B195.0022.2911.78%9.08%13.8%0.95
NVCR logoNVCRNovoCure LimitedProduct Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85

Compare FTRE vs Peers

Fortrea Holdings Inc. (FTRE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs IQV

Most directly comparable listed peer for FTRE.

Scale Benchmark

vs TMO

Larger-name benchmark to compare FTRE against a more recognizable public peer.

Peer Set

Compare Top 5

vs IQV, CRL, MEDP, PRA

FTRE Income Statement

Fortrea Holdings Inc. (FTRE) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
3.06B2.84B2.84B2.7B2.72B2.71B
Revenue Growth %
--7.21%0.19%-5.14%1%0.86%
Cost of Goods Sold
2.45B2.11B2.25B2.16B2.3B1.74B
COGS % of Revenue
80.23%74.47%79.22%80.19%84.37%-
Gross Profit
604.4M▲ 0%
724.4M▲ 19.9%
590.6M▼ 18.5%
534.2M▼ 9.5%
425.8M▼ 20.3%
328.8M▲ 0%
Gross Margin %
19.77%25.53%20.78%19.81%15.63%12.14%
Gross Profit Growth %
-19.85%-18.47%-9.55%-20.29%-
Operating Expenses
490.1M537.3M558.6M696.1M456.4M447.3M
OpEx % of Revenue
16.03%18.94%19.65%25.82%16.76%-
Selling, General & Admin
303.1M416.1M448.1M560.7M456.4M435.1M
SG&A % of Revenue
9.91%14.67%15.76%20.79%16.76%-
Research & Development
000000
R&D % of Revenue
------
Other Operating Expenses
187M121.2M110.5M135.4M01000K
Operating Income
114.3M▲ 0%
187.1M▲ 63.7%
32M▼ 82.9%
-161.9M▼ 605.9%
-30.6M▲ 81.1%
-30.3M▲ 0%
Operating Margin %
3.74%6.59%1.13%-6%-1.12%-1.12%
Operating Income Growth %
-63.69%-82.9%-605.94%81.1%-
EBITDA
280.6M280.7M130M-75M47.4M48M
EBITDA Margin %
9.18%9.89%4.57%-2.78%1.74%1.77%
EBITDA Growth %
-0.04%-53.69%-157.69%163.2%108.55%
D&A (Non-Cash Add-back)
166.3M93.6M98M86.9M78M78.3M
EBIT
136.6M187.2M39.2M-151.2M-891.6M-366M
Net Interest Income
-200K-200K-69.7M-123.8M-91.4M-69M
Interest Income
000000
Interest Expense
200K200K69.8M123.8M91.4M49.9M
Other Income/Expense
22.1M-100K-62.5M-113.1M-952.4M-417M
Pretax Income
136.4M▲ 0%
187M▲ 37.1%
-30.5M▼ 116.3%
-275M▼ 801.6%
-983M▼ 257.5%
-447.3M▲ 0%
Pretax Margin %
4.46%6.59%-1.07%-10.2%-36.09%-16.51%
Income Tax
38.4M41.1M1.2M-3.5M3.2M-400K
Effective Tax Rate %
28.15%21.98%-3.93%1.27%-0.33%0.09%
Net Income
98M▲ 0%
186.2M▲ 90.0%
-25.2M▼ 113.5%
-328.5M▼ 1203.6%
-986.2M▼ 200.2%
-446.9M▲ 0%
Net Margin %
3.21%6.56%-0.89%-12.18%-36.21%-16.5%
Net Income Growth %
-90%-113.53%-1203.57%-200.21%43.46%
Net Income (Continuing)
98M145.9M-31.7M-271.5M-986.2M-446.9M
Discontinued Operations
040.3M6.5M-57M00
Minority Interest
000000
EPS (Diluted)
1.11▲ 0%
2.11▲ 90.1%
-0.04▼ 101.9%
-3.67▼ 9075.0%
-10.81▼ 194.6%
-4.90▲ 0%
EPS Growth %
-90.09%-101.9%-9075%-194.55%44.21%
EPS (Basic)
1.112.11-0.04-3.67-10.81-
Diluted Shares Outstanding
88.4M88.4M88.8M89.5M91.2M91.2M
Basic Shares Outstanding
88.4M88.4M88.8M89.5M91.2M91.2M
Dividend Payout Ratio
------

FTRE Balance Sheet

Fortrea Holdings Inc. (FTRE) balance sheet — assets, liabilities & shareholders' equity

MetricDec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
1.12B1.25B1.25B948.2M897.2M881.5M
Cash & Short-Term Investments
94.6M112M108.6M118.5M174.6M147.5M
Cash Only
94.6M112M108.6M118.5M174.6M147.5M
Short-Term Investments
000000
Accounts Receivable
949.8M1.05B1.01B694M589.7M619.6M
Days Sales Outstanding
113.39135.27129.7693.9479.0387.99
Inventory
000000
Days Inventory Outstanding
------
Other Current Assets
73.1M50.8M97.6M77.2M132.9M114.4M
Total Non-Current Assets
3.25B3.04B3.08B2.63B1.82B1.8B
Property, Plant & Equipment
162.6M164.9M172.6M156.3M149.5M157.1M
Fixed Asset Turnover
18.80x17.20x16.47x17.25x18.22x17.97x
Goodwill
2.08B2B1.74B1.71B960M950.8M
Intangible Assets
935.5M823.3M728.1M655.7M622M601.7M
Long-Term Investments
000000
Other Non-Current Assets
70.8M54.3M438.5M103.4M80.8M86.1M
Total Assets
4.37B▲ 0%
4.29B▼ 1.8%
4.33B▲ 1.0%
3.58B▼ 17.4%
2.72B▼ 24.1%
2.68B▲ 0%
Asset Turnover
0.70x0.66x0.66x0.75x1.00x0.99x
Asset Growth %
--1.85%1.04%-17.39%-24.13%-83.79%
Total Current Liabilities
826.7M699M778.4M949.5M913.3M929.1M
Accounts Payable
60.5M81.5M132.9M138.2M29.7M70.8M
Days Payables Outstanding
914.0821.5423.334.7212.7
Short-Term Debt
0026.1M74.8M14M19.7M
Deferred Revenue (Current)
307M271.5M214.2M353.3M473.8M1.75B
Other Current Liabilities
178.5M150.1M185.9M129.6M395.8M357.3M
Current Ratio
1.35x1.78x1.61x1.00x0.98x0.95x
Quick Ratio
1.35x1.78x1.61x1.00x0.98x0.95x
Cash Conversion Cycle
-----75.29
Total Non-Current Liabilities
281.4M246.3M1.84B1.27B1.24B1.23B
Long-Term Debt
001.57B1.05B54M55.7M
Capital Lease Obligations
53.2M40.1M62.8M60.6M0104.4M
Deferred Tax Liabilities
210.3M184.5M147.7M121.7M97.6M409.6M
Other Non-Current Liabilities
17.9M21.7M63.7M35.3M1.09B1.08B
Total Liabilities
1.11B945.3M2.62B2.22B2.15B2.16B
Total Debt
77.2M63.4M1.67B1.2B68M75.4M
Net Debt
-17.4M-48.6M1.56B1.08B-106.6M-72.1M
Debt / Equity
0.02x0.02x0.98x0.88x0.12x0.14x
Debt / EBITDA
0.28x0.23x12.86x-1.43x1.57x
Net Debt / EBITDA
-0.06x-0.17x12.03x--2.25x-1.50x
Interest Coverage
683.00x936.00x0.56x-1.22x-9.75x-7.33x
Total Equity
3.26B▲ 0%
3.34B▲ 2.5%
1.71B▼ 48.7%
1.36B▼ 20.5%
563.5M▼ 58.6%
525.9M▲ 0%
Equity Growth %
-2.51%-48.72%-20.52%-58.64%-218.7%
Book Value per Share
36.8837.8119.3015.226.185.77
Total Shareholders' Equity
3.26B3.34B1.71B1.36B563.5M525.9M
Common Stock
00100K100K100K100K
Retained Earnings
00-68.5M-397M-1.38B-1.41B
Treasury Stock
000000
Accumulated OCI
-148.4M-276M-215.5M-282.9M-170M-195.4M
Minority Interest
000000

FTRE Cash Flow Statement

Fortrea Holdings Inc. (FTRE) cash flow — operating, investing & free cash flow history

MetricDec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
169.8M82.7M168.4M262.8M113.5M237.7M
Operating CF Margin %
5.55%2.92%5.92%9.75%4.17%-
Operating CF Growth %
--51.3%103.63%56.06%-56.81%4379.6%
Net Income
98M186.2M-25.2M-271.5M-986.2M-446.9M
Depreciation & Amortization
166.3M93.6M98M98M78M58.5M
Stock-Based Compensation
27.5M25.4M42.7M58.4M74.4M59.8M
Deferred Taxes
-30.2M-16.5M-41.6M-24.6M-32M-25.4M
Other Non-Cash Items
35.4M42.2M67.6M38M864.6M382.6M
Working Capital Changes
-127.2M-248.2M26.9M364.5M114.7M185.5M
Change in Receivables
-187.6M-108.4M-53.4M309.9M70.9M141.4M
Change in Inventory
000000
Change in Payables
-6.2M24.8M55.3M7.2M-109.9M-81.5M
Cash from Investing
-26.2M-54M-31.8M251.6M14.4M-1.7M
Capital Expenditures
-26.5M-54.4M-40.3M-25.5M-25.2M-22.3M
CapEx % of Revenue
0.87%1.92%1.42%0.95%0.93%0.82%
Acquisitions
000276.6M020.6M
Investments
------
Other Investing
300K400K8.5M500K39.6M0
Cash from Financing
-128.5M-6.3M-140.8M-497.8M-76.3M-164.7M
Debt Issued (Net)
001.62B-482.7M-76.3M-164.7M
Equity Issued (Net)
000000
Dividends Paid
000000
Share Repurchases
000000
Other Financing
-128.5M-6.3M-1.76B-15.1M00
Net Change in Cash
14.3M▲ 0%
15.8M▲ 10.5%
-1.8M▼ 111.4%
9.9M▲ 650.0%
56.1M▲ 466.7%
45.9M▲ 0%
Free Cash Flow
143.3M▲ 0%
28.3M▼ 80.3%
128.1M▲ 352.7%
237.3M▲ 85.2%
88.3M▼ 62.8%
215.4M▲ 0%
FCF Margin %
4.69%1%4.51%8.8%3.24%7.95%
FCF Growth %
--80.25%352.65%85.25%-62.79%48.45%
FCF per Share
1.620.321.442.650.972.36
FCF Conversion (FCF/Net Income)
1.73x0.44x-6.68x-0.80x-0.12x-0.48x
Interest Paid
000000
Taxes Paid
000000

FTRE Key Ratios

Fortrea Holdings Inc. (FTRE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2022202320242025TTM
Return on Equity (ROE)
5.64%-1%-21.36%-102.41%-79.12%
Return on Invested Capital (ROIC)
4.29%0.73%-4.25%-1.58%-2.12%
Gross Margin
25.53%20.78%19.81%15.63%12.14%
Net Margin
6.56%-0.89%-12.18%-36.21%-16.5%
Debt / Equity
0.02x0.98x0.88x0.12x0.14x
Interest Coverage
936.00x0.56x-1.22x-9.75x-7.33x
FCF Conversion
0.44x-6.68x-0.80x-0.12x-0.48x
Revenue Growth
-7.21%0.19%-5.14%1%0.86%
Related:FTRE Dividend History·FTRE Revenue History·FTRE Price History·FTRE P/E History·FTRE Financial Ratios·FTRE Institutional Holders

FTRE SEC Filings & Documents

Fortrea Holdings Inc. (FTRE) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Nov 20, 2025·SEC

10-K Annual Reports

3
FY 2026

Feb 26, 2026·SEC

FY 2025

Mar 3, 2025·SEC

FY 2024

Mar 13, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FTRE Frequently Asked Questions

Fortrea Holdings Inc. (FTRE) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Fortrea Holdings Inc. (FTRE) reported $2.71B in revenue for fiscal year 2025. This represents a 11% decrease from $3.06B in 2021.

Fortrea Holdings Inc. (FTRE) grew revenue by 1.0% over the past year. Growth has been modest.

Fortrea Holdings Inc. (FTRE) reported a net loss of $446.9M for fiscal year 2025.

Dividend & Returns

Fortrea Holdings Inc. (FTRE) has a return on equity (ROE) of -102.4%. Negative ROE indicates the company is unprofitable.

Fortrea Holdings Inc. (FTRE) generated $215.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in FTRE back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →

How much would $100/month in FTRE be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →